Articles & Research

Ketamine was initially developed as an anesthetic, but it has recently gained attention as a promising treatment for mental health conditions, particularly depression. In 2000, the first clinical trial demonstrated that ketamine could produce rapid and long-lasting improvements in patients with depression. Since then, numerous studies have underscored its potential to treat severe depression as

Ketamine nasal spray, specifically the FDA-approved Spravato (esketamine), has become a game-changer for those struggling with treatment-resistant depression. As this therapy gains traction in the DMV area, understanding how long its effects last is crucial for patients considering this treatment. In this blog post, we explore the duration of ketamine nasal spray effects, factors that

Mental wellness is a vital aspect of overall health, impacting how we think, feel, and act. In McLean, Virginia, individuals are increasingly recognizing the importance of a holistic approach to mental health. By integrating lifestyle changes with holistic interventional treatments, residents can cultivate a balanced and fulfilling life. This blog explores various lifestyle changes that

In McLean, Virginia, those struggling with treatment-resistant depression now have a new beacon of hope: esketamine therapy. Available at certified Spravato treatment centers, this innovative treatment offers a lifeline to individuals who have not found relief with traditional antidepressants. Here, we explore what patients can expect during Spravato treatment and how it can transform lives.

For those in McLean, Virginia, struggling with treatment-resistant depression, finding effective relief can be a daunting challenge. Fortunately, esketamine treatment, available at certified Spravato treatment centers like McLean Neuropsychiatric Center, offers a promising solution. We find, it’s natural for prospective patients to have reservations about new treatments. It is our hope that our experienced, patient

For residents of McLean, VA, finding effective treatments for depression is a pressing concern. Traditional antidepressants and therapies do not work for everyone, and for those with treatment-resistant depression, the journey to finding relief can be long and challenging. However, an innovative option known as Spravato (esketamine) offers new hope. In this blog post, we